Tirzepatide, the active ingredient in Eli Lillys diabetes drug Mounjaro and weight-loss medication Zepbound, was on the US Food and Drug Administrations shortage list from December 2022 until October 2, 2024
It works by mimicking the action of hormones in the body that regulate appetite and food intake
No ones perfect
You wont find artificial dyes, chemical sweeteners, or unnecessary fillers in this formula
While both drug companies provide warning labels about common side effects of their GLP-1 medications, their labels may not provide adequate warning about severe complications such as stomach paralysis, intestinal blockages, or bowel obstruction
If you are considering or currently using GLP-1 therapy and wish to protect your muscle, strength, and structural health while achieving meaningful fat loss, we invite you to book a consultation with our team